title: Prolactin may not play a role in primary antiphospholipid (Hughes') syndrome.
abstract: The relationship between prolactin (PRL) and the immune system has been demonstrated in the last two decades and has opened new windows in the field of immunoendocrinology. However, there are scarce reports about PRL in primary antiphospholipid syndrome (pAPS). The objective of this study was to evaluate PRL levels in patients with pAPS compared to healthy controls and to investigate their possible clinical associations. Fifty-five pAPS patients according to Sapporo criteria were age- and sex-matched with 41 healthy subjects. Individuals with secondary causes of hyperprolactinemia (HPRL) were excluded; demographic, biometric, and clinical data, PRL levels, antiphospholipid antibodies, inflammatory markers, and other routine laboratory findings were analyzed. PRL levels were similar between pAPS and healthy controls (8.94 ± 7.02 versus 8.71 ± 6.73 ng/mL, P = .876). Nine percent of the pAPS patients and 12.1% of the control subjects presented HPRL (P = .740). Comparison between the pAPS patients with hyper- and normoprolactinemia revealed no significant differences related to anthropometrics, clinical manifestations, medications, smoking, and antiphospholipid antibodies (P > .05). This study showed that HPRL does not seem to play a role in clinical manifestations of the pAPS, differently from other autoimmune rheumatic diseases.
authors: Disciplina de Reumatologia, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, No. 455, 3 Andar, Sala 3190, 01246-903 Sao Paulo, SP, Brazil.
authors: Manoel Tavares
authors: MT
authors: Neves Junior
authors: Carlos Ewerton Maia
authors: CE
authors: Rodrigues
authors: Jozelio Freire
authors: JF
authors: de Carvalho
references: Ann N Y Acad Sci. 1999 Jun 22;876:119-30
references: 10415600
references: Autoimmun Rev. 2007 Sep;6(8):537-42
references: 17854745
references: Mol Hum Reprod. 2006 Jul;12(7):435-42
references: 16735457
references: Lupus. 2010 Nov;19(13):1515-9
references: 20647249
references: Thromb Res. 2002 Dec 15;108(5-6):263-71
references: 12676184
references: Br Med J. 1975 Dec 27;4(5999):738-9
references: 1212585
references: Physiol Rev. 2000 Oct;80(4):1523-631
references: 11015620
references: Thromb Haemost. 2006 Jun;95(6):917-9
references: 16732366
references: Acta Biomed. 2007;78 Suppl 1:255-61
references: 17465339
references: Arthritis Rheum. 2003 Aug;48(8):2100-10
references: 12905462
references: Lupus. 1998;7(6):377-82
references: 9736319
references: Clin Rev Allergy Immunol. 2011 Feb;40(1):50-9
references: 19911311
references: J Rheumatol. 1998 Dec;25(12):2357-63
references: 9858430
references: Science. 1972 Sep 29;177(4055):1205-7
references: 5057627
references: Thromb Haemost. 2009 Jun;101(6):1119-27
references: 19492157
references: Lupus. 1998;7(6):398-403
references: 9736323
references: Am J Obstet Gynecol. 1973 Jun 1;116(3):377-87
references: 4196484
references: Obes Surg. 2009 Aug;19(8):1159-62
references: 19430852
references: J Neuroimmunol. 1993 Aug;47(1):35-40
references: 8376547
references: Am J Med Sci. 1992 Apr;303(4):222-6
references: 1562038
references: Lupus. 2001;10(5):340-5
references: 11403264
references: Pituitary. 2005;8(1):25-30
references: 16411065